• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

孕期抗Kell血型同种免疫的当前临床管理

Current clinical management of anti-Kell alloimmunization in pregnancy.

作者信息

Santiago Juan C, Ramos-Corpas Domingo, Oyonarte Salvador, Montoya Francisco

机构信息

Unidad de Medicina Fetal, Servicio de Obstetricia y Ginecología del Hospital Universitario V. De las Nieves, 180-Granada, Spain.

出版信息

Eur J Obstet Gynecol Reprod Biol. 2008 Feb;136(2):151-4. doi: 10.1016/j.ejogrb.2007.03.003. Epub 2007 May 3.

DOI:10.1016/j.ejogrb.2007.03.003
PMID:17481801
Abstract

OBJECTIVES

Few reports have been published of the current clinical management of anti-Kell alloimmunization in pregnancy; its low frequency of occurrence means that the few long series published have covered very ample time periods in which different kinds of clinical management have overlapped. The objective of the present paper is to present our experience in the current clinical management of pregnant women who are positive for the anti-Kell antibody.

STUDY DESIGN

A retrospective analysis was carried out of the case histories of pregnant women who were alloimmunized for the Kell antigen and who were studied and/or treated at the Department of Fetal Medicine in the Virgen de las Nieves University Hospital in Granada (Spain), between 2000 and 2004. The clinical management included the basal measurement of the titre of antibodies, the identification of the paternal phenotype (and that of the fetus, if necessary), the ultrasonographic monitoring of the fetus to detect signs of anaemia, sampling of fetal blood by cordocentesis when fetal anaemia was suspected, and fetal intravascular transfusion when necessary.

RESULTS

Of the 10 pregnancies with anti-Kell antibodies, The Kell antigen was confirmed in the fetus in three cases, in all of which moderate to severe fetal anaemia developed, requiring fetal intravascular transfusions. Although one of the fetus developed antenatal hydrops, a good perinatal result was advised.

CONCLUSIONS

The current approach to anti-Kell alloimmunization enables pregnant women who have Kell-positive fetuses to be treated successfully.

摘要

目的

关于孕期抗凯尔同种免疫的当前临床管理的报道很少;其发生频率较低,意味着已发表的少数长系列研究涵盖了很长的时间段,在此期间不同类型的临床管理相互重叠。本文的目的是介绍我们在抗凯尔抗体阳性孕妇的当前临床管理方面的经验。

研究设计

对2000年至2004年期间在西班牙格拉纳达的拉斯涅韦斯圣母大学医院胎儿医学科接受研究和/或治疗的因凯尔抗原发生同种免疫的孕妇病历进行回顾性分析。临床管理包括抗体滴度的基础测量、父亲表型(必要时包括胎儿表型)的鉴定、超声监测胎儿以检测贫血迹象、怀疑胎儿贫血时通过脐静脉穿刺采集胎儿血液以及必要时进行胎儿血管内输血。

结果

在10例抗凯尔抗体阳性的妊娠中,3例胎儿确诊为凯尔抗原阳性,所有这些胎儿均出现中度至重度胎儿贫血,需要进行胎儿血管内输血。尽管其中1例胎儿出现产前水肿,但围产期结局良好。

结论

当前对抗凯尔同种免疫的处理方法能够成功治疗胎儿为凯尔阳性的孕妇。

相似文献

1
Current clinical management of anti-Kell alloimmunization in pregnancy.孕期抗Kell血型同种免疫的当前临床管理
Eur J Obstet Gynecol Reprod Biol. 2008 Feb;136(2):151-4. doi: 10.1016/j.ejogrb.2007.03.003. Epub 2007 May 3.
2
Obstetric history and antibody titer in estimating severity of Kell alloimmunization in pregnancy.产科病史和抗体滴度在评估孕期凯尔血型同种免疫的严重程度中的作用
Obstet Gynecol. 2007 May;109(5):1093-8. doi: 10.1097/01.AOG.0000260957.77090.4e.
3
Management of pregnancies complicated by anti-E alloimmunization.抗-E同种免疫所致妊娠并发症的管理。
Obstet Gynecol. 2005 Jan;105(1):24-8. doi: 10.1097/01.AOG.0000149153.93417.66.
4
Kell alloimmunization in pregnancy: associated with fetal thrombocytopenia?孕期凯尔血型同种免疫:与胎儿血小板减少有关吗?
Vox Sang. 2008 Jul;95(1):66-9. doi: 10.1111/j.1423-0410.2008.01061.x. Epub 2008 Apr 23.
5
Kell alloimmunization, hemolytic disease of the newborn, and perinatal management.凯尔血型同种免疫、新生儿溶血病及围产期管理。
Obstet Gynecol. 1985 Oct;66(4):473-6.
6
[Haemolytic disease of the newborn--from a mother with anti-Kell, anti-E and anti-Vel anti-erythrocyte alloantibodies].[新生儿溶血病——源于一位携带抗Kell、抗E和抗Vel红细胞同种抗体的母亲]
Z Geburtshilfe Neonatol. 2004 Oct;208(5):197-202. doi: 10.1055/s-2004-832639.
7
Maternal Kell blood group alloimmunization.
Obstet Gynecol. 1992 Feb;79(2):239-44.
8
Effect of screening for red cell antibodies, other than anti-D, to detect hemolytic disease of the fetus and newborn: a population study in the Netherlands.除抗-D外筛查红细胞抗体以检测胎儿和新生儿溶血病的效果:荷兰的一项人群研究
Transfusion. 2008 May;48(5):941-52. doi: 10.1111/j.1537-2995.2007.01625.x. Epub 2008 Feb 1.
9
Management of anti-Jka alloimmunization.抗Jka同种免疫的管理。
J Reprod Med. 2009 Mar;54(3):121-5.
10
Implementation of routine screening for Kell antibodies: does it improve perinatal survival?实施凯尔抗体常规筛查:能否提高围产期存活率?
Transfusion. 2008 May;48(5):953-7. doi: 10.1111/j.1537-2995.2007.01626.x. Epub 2008 Feb 1.

引用本文的文献

1
Distribution of Kell phenotype among pregnant women in Sokoto, North Western Nigeria.尼日利亚西北部索科托孕妇的凯尔血型表型分布
Pan Afr Med J. 2015 Aug 26;21:301. doi: 10.11604/pamj.2015.21.301.4636. eCollection 2015.
2
Molecular assays as tools to facilitate new discoveries and to enhance immunohematology in daily transfusion practice.分子检测作为促进新发现和提升日常输血实践中免疫血液学水平的工具。
Rev Bras Hematol Hemoter. 2013;35(2):81-2. doi: 10.5581/1516-8484.20130023.